Search details
1.
Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population.
Cardiovasc Diabetol
; 23(1): 18, 2024 01 06.
Article
in English
| MEDLINE | ID: mdl-38184588
2.
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states.
Cardiovasc Diabetol
; 23(1): 25, 2024 01 13.
Article
in English
| MEDLINE | ID: mdl-38218814
3.
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Cardiovasc Diabetol
; 22(1): 220, 2023 08 24.
Article
in English
| MEDLINE | ID: mdl-37620807
4.
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.
Cardiovasc Diabetol
; 22(1): 208, 2023 08 11.
Article
in English
| MEDLINE | ID: mdl-37568149
5.
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population.
J Card Fail
; 28(7): 1050-1062, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35550428
6.
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.
Cardiovasc Diabetol
; 21(1): 129, 2022 07 08.
Article
in English
| MEDLINE | ID: mdl-35804351
7.
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study.
Cardiovasc Diabetol
; 21(1): 195, 2022 09 23.
Article
in English
| MEDLINE | ID: mdl-36151569
8.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Article
in English
| MEDLINE | ID: mdl-33197271
9.
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Cardiovasc Diabetol
; 20(1): 38, 2021 02 11.
Article
in English
| MEDLINE | ID: mdl-33573665
10.
Copeptin is associated with mortality in elderly people.
Eur J Clin Invest
; 51(7): e13516, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33569762
11.
Effect of dipeptidyl peptidase-4 inhibitors on complement activation.
Diabetes Metab Res Rev
; 37(3): e3385, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32662092
12.
Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials.
Eur Heart J
; 45(15): 1371-1374, 2024 Apr 14.
Article
in English
| MEDLINE | ID: mdl-38416593
13.
Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
Heart Lung Circ
; 26(2): 143-149, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27523461
14.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Eur Heart J
; 41(2): 255-323, 2020 01 07.
Article
in English
| MEDLINE | ID: mdl-31497854
15.
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Cardiovasc Diabetol
; 14: 133, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26427624
16.
The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
Eur Heart J
; 34(5): 374-9, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23144046
17.
Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
Eur Heart J
; 34(40): 3137-44, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23999452
18.
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.
Diabetes Care
; 47(2): 246-251, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38055929
19.
Implementation of an extracorporeal resuscitation (ECPR) program for out-of-hospital cardiac arrest in Stockholm, Sweden: Feasibility, safety, and outcome.
Resusc Plus
; 18: 100596, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38486930
20.
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
Eur J Heart Fail
; 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38783712